Development of Novel Therapies in Murine Models for Gaucher Disease

被引：0
|
作者：
Enquist, Ida Berglin [1 ]
Nilsson, Eva [1 ]
Lo Bianco, Christophe [1 ]
Mansson, Jan-Eric [1 ]
Ehinger, Mats [1 ]
Brady, Roscoe O. [1 ]
Richter, Johan [1 ]
Karlsson, Stefan [1 ]
机构：
[1] Univ Lund Hosp, BMC A12, Dept Mol Med & Gene Therapy, Lund Stem Cell Ctr, S-22184 Lund, Sweden
来源：
CLINICAL THERAPEUTICS | 2009年 / 31卷
关键词：
CELL;
D O I：
10.1016/S0149-2918(09)80022-2
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：S198 / S199
页数：2
相关论文
共 50 条
  • [21] Progranulin as a Novel Factor in Gaucher Disease
    Choy, Francis Y. M.
    Christensen, Chloe L.
    EBIOMEDICINE, 2016, 13 : 13 - 14
  • [22] Effects of small molecule therapies on lysosomal function in Gaucher disease
    Ivanova, Margarita
    Dao, Julia
    Sharief, Nida
    Goker-Alpan, Ozlem
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S78 - S79
  • [23] Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies
    Anstee, Q. M.
    Goldin, R. D.
    Wright, M.
    Martinelli, A.
    Cox, R.
    Thursz, M. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (08) : 1336 - 1343
  • [24] Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies
    Wagner, Victoria F.
    Northrup, Hope
    Hashmi, S. Shahrukh
    Nguyen, Joanne M.
    Koenig, Mary Kay
    Davis, Jessica M.
    JOURNAL OF GENETIC COUNSELING, 2018, 27 (01) : 169 - 176
  • [25] Development of a novel ingestible macrophage-targeted gene therapy for Gaucher disease
    Ginns, Edward
    Lim, Arlene
    Galdzicke, Marzena
    Faryna, Deborah
    Ostroff, Gary
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S22 - S22
  • [26] Development of a novel orally administered gene expression therapy for Gaucher disease.
    Ostroff, GR
    Faryna, DM
    Chrzanowski, C
    Galdzicka, M
    Ginns, EI
    MOLECULAR GENETICS AND METABOLISM, 2005, 84 (03) : 220 - 220
  • [27] Development of human leukemia in murine models is associated with de novo angiogenesis: Relevance for the design of novel anti-leukemia therapies
    Veiga, P
    Sallan, S
    Nadler, L
    Cardoso, A
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 71 - 71
  • [28] Validation of an autologous transplant approach to testing novel gene therapies in transgenic murine models of human sickle cell disease.
    Miller, CL
    Antonchuk, J
    Fabry, ME
    Nagel, RL
    Humphries, RK
    Eaves, CJ
    BLOOD, 1997, 90 (10) : 1037 - 1037
  • [29] Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
    Hughes, Derralynn A.
    Deegan, Patrick
    Giraldo, Pilar
    Goker-Alpan, Ozlem
    Lau, Heather
    Lukina, Elena
    Revel-Vilk, Shoshana
    Scarpa, Maurizio
    Botha, Jaco
    Gadir, Noga
    Zimran, Ari
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (17)
  • [30] Development of novel therapies for Huntington's disease: hope and challenge
    Qin, ZH
    Wang, J
    Gu, ZL
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (02) : 129 - 142
12345